Polycyclic aromatic hydrocarbons and their metabolites in bronchoalveolar lavage and urine samples from patients with inhalation injury throughout their hospitalization: A prospective pilot study.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Original Publication: San Francisco, CA : Public Library of Science

Polycyclic Aromatic Hydrocarbons*/urine ; Polycyclic Aromatic Hydrocarbons*/analysis ; Bronchoalveolar Lavage Fluid*/chemistry ; Hospitalization*; Humans ; Male ; Pilot Projects ; Female ; Middle Aged ; Prospective Studies ; Aged ; Adult

Background: Specific toxic compounds, such as polycyclic aromatic hydrocarbons (PAHs) and their metabolites, may affect the inhalation injury (INHI) grade, patients' status, and prognosis for recovery. This pilot prospective study aimed to: i) evaluate the suitability of bronchoalveolar lavage (BAL) for determination of PAHs in the LRT and of urine for determination of hydroxylated metabolites (OH-PAHs) in patients with INHI, ii) describe the dynamic changes in the levels of these toxic compounds, and iii) correlate these findings with clinical variables of the patients with INHI.
Methods: The BAL and urine samples from 10 patients with INHI were obtained on Days 1, 3, 5, 7, and 14 of hospitalization, if possible, and PAHs (BAL) and OH-PAHs (urine) were analyzed using chromatographic methods (GC-MS and HPLC).
Results: Concentrations of analyzed PAHs were in most cases and time points below the limit of quantification in BAL samples. Nine OH-PAHs were detected in the urine samples; however, their concentrations sharply decreased within the first three days of the hospitalization. On Day 14, the total amount of OH-PAHs in urine was higher in surviving patients with High-grade INHI (≥3) than in those with Low-grade INHI (<3, p = 0.032). Finally, a significant correlation between certain OH-PAHs and clinical variables (AST/ALT, TBSA, ABSI) from Day 1 of the hospitalization was observed (p<0.05).
Conclusions: BAL samples are not suitable for the analysis of PAHs. However, the OH-PAHs levels in urine can be measured reliably and were correlated with several clinical variables. Moreover, High-grade INHI was associated with higher total concentrations of OH-PAHs in urine.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright: © 2024 Vyklicka et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)

Emerg Med Clin North Am. 2003 May;21(2):533-57. (PMID: 12793627)
J Burn Care Res. 2008 Sep-Oct;29(5):852-5. (PMID: 18695605)
J Burn Care Res. 2014 May-Jun;35(3):e180-3. (PMID: 24784905)
N Engl J Med. 2010 Dec 2;363(23):2233-47. (PMID: 21121836)
Int J Hyg Environ Health. 2021 May;234:113740. (PMID: 33774419)
Respir Med. 2020 Sep;171:106082. (PMID: 32658839)
Inhal Toxicol. 2009 Nov;21(13):1144-7. (PMID: 19852557)
Crit Care. 2015 Oct 28;19:351. (PMID: 26507130)
Ann Plast Surg. 2018 Mar;80(3 Suppl 2):S98-S105. (PMID: 29461292)
Mediastinum. 2021 Jun 25;5:16. (PMID: 35118322)
Inhal Toxicol. 2008 Jun;20(8):761-6. (PMID: 18569098)
Environ Int. 2016 Dec;97:171-179. (PMID: 27622755)
Ann Emerg Med. 1982 May;11(5):260-2. (PMID: 7073049)
Mil Med. 2018 Sep 1;183(suppl_2):130-132. (PMID: 30189064)
Expert Rev Respir Med. 2009 Jun 1;3(3):283-297. (PMID: 20161170)
Medicine (Baltimore). 2017 Dec;96(48):e8972. (PMID: 29310404)
Burns. 2005 Nov;31(7):925-9. (PMID: 16199299)
Crit Care Med. 2012 Apr;40(4):1113-21. (PMID: 22067627)
Ann Am Thorac Soc. 2018 Nov;15(Suppl 3):S143-S148. (PMID: 30431340)
Anal Bioanal Chem. 2017 Feb;409(4):931-937. (PMID: 27796450)
Clin Sci (Lond). 2004 Aug;107(2):137-43. (PMID: 15151496)
Environ Sci Pollut Res Int. 2023 May;30(22):62981-62992. (PMID: 36952158)
J Burn Care Res. 2019 Aug 14;40(5):570-584. (PMID: 31214710)
Cureus. 2022 Jun 21;14(6):e26161. (PMID: 35891871)
Scand J Trauma Resusc Emerg Med. 2013 Apr 19;21:31. (PMID: 23597126)
Burns. 2022 Sep;48(6):1386-1395. (PMID: 34924231)
J Trace Elem Med Biol. 2022 Mar;70:126912. (PMID: 34954563)

0 (Polycyclic Aromatic Hydrocarbons)

Date Created: 20240801 Date Completed: 20240801 Latest Revision: 20240803

20240803

PMC11293749

10.1371/journal.pone.0308163

39088550